Selective anti-proliferation of HER2-positive breast cancer cells by anthocyanins identified by high-throughput screening

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Liu, Weihua ^a   Xu, Jinmei ^a   Wu, Shaoping ^a   Liu, Yilun ^a   Yu, Xiaoping ^a   Chen, Juan ^b   Tang, Xi ^a   Wang, Zhi ^a   Zhu, Xiaohu ^a   Li, Xin ^a  

^a CHENGDU MEDICAL COLLEGE   (China)

^b University of Traditional Chinese Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHOCYANIN; CASPASE 3; CASPASE 7; CATALPOL; CYANIDIN 3 GLUCOSIDE; DIGOXIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EUROPINIDIN; LEONURINE; METHYL PROTODIOSCIN; NATURAL PRODUCT; PEONIDIN 3 GLUCOSIDE; PROTEIN KINASE B; QUERCETIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER SIZE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SELECTIVITY; DRUG STRUCTURE; FEMALE; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; TREATMENT DURATION; TUMOR XENOGRAFT;

ANIMALS; ANTHOCYANINS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MICE; RECEPTOR, ERBB-2; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84891706296     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081586     Document Type: Article

References (38)

1. Ziegler RG, Anderson WF, Gail MH (2008) Increasing breast cancer incidence in China: the numbers add up. J Natl Cancer Inst 100: 1339-1341.
2. Vrbic S, Pejcic I, Filipovic S, Kocic B, Vrbic M (2013) Current and future anti- HER2 therapy in breast cancer. J buon 18: 4-16.
3. Marty M, Cognetti F, Maraninchi D, Snyder R, Mauriac L, et al. (2005) Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group. J Clin Oncol 23: 4265-4274.
4. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, et al. (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10: 515-527.
5. Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, et al. (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344: 783-792.
6. Huang C, Lee SY, Lin CL, Tu TH, Chen LH, et al. (2013) Co-treatment with Quercetin and 1,2,3,4,6-Penta-O-galloyl-beta-d-glucose Causes Cell Cycle Arrest and Apoptosis in Human Breast Cancer MDA-MB-231 and AU565 Cells. J Agric Food Chem 61: 6430-6445.
7. Wu XQ, Shao SJ, Qu WC (2012) [Effects of ru'ai shuhou recipe on the matrix metalloproteinases and the inhibitive factors in the recurrence and metastasis of HER2 positive breast cancer]. Zhongguo Zhong Xi Yi Jie He Za Zhi 32: 1526-1530.
8. Liang M, Liu X, Cheng D, Liu G, Dou S, et al. (2010) Multimodality nuclear and fluorescence tumor imaging in mice using a streptavidin nanoparticle. Bioconjug Chem 21: 1385-1388.
9. Inglese J, Shamu CE, Guy RK (2007) Reporting data from high-throughput screening of small-molecule libraries. Nature chemical biology 3: 438-441.
10. Chen XQ, Nagao N, Itani T, Irifune K (2012) Anti-oxidative analysis, and identification and quantification of anthocyanin pigments in different coloured rice. Food Chem 135: 2783-2788.
11. Fernandes I, Faria A, Azevedo J, Soares S, Calhau C, et al. (2010) Influence of anthocyanins, derivative pigments and other catechol and pyrogallol-type phenolics on breast cancer cell proliferation. J Agric Food Chem 58: 3785-3792.
12. Bunea A, Rugina D, Sconta Z, Pop RM, Pintea A, et al. (2013) Anthocyanin determination in blueberry extracts from various cultivars and their antiproliferative and apoptotic properties in B16-F10 metastatic murine melanoma cells. Phytochemistry.
13. Fernandes I, Marques F, de Freitas V, Mateus N (2013) Antioxidant and antiproliferative properties of methylated metabolites of anthocyanins. Food Chem 141: 2923-2933.
14. Heinonen M (2007) Antioxidant activity and antimicrobial effect of berry phenolics-a Finnish perspective. Mol Nutr Food Res 51: 684-691.
15. Iriti M, Varoni EM (2013) Chemopreventive potential of flavonoids in oral squamous cell carcinoma in human studies. Nutrients 5: 2564-2576.
16. Kamenickova A, Anzenbacherova E, Pavek P, Soshilov AA, Denison MS, et al. (2013) Effects of anthocyanins on the AhR-CYP1A1 signaling pathway in human hepatocytes and human cancer cell lines. Toxicol Lett 221: 1-8.
17. Dong Z, Chen CX (2013) Effect of catalpol on diabetic nephropathy in rats. Phytomedicine 20: 1023-1029.
18. Feng Y, Liu Z, Peng Y, Zhang L, Ju P, et al. (2013) Validated LC-MS method for simultaneous quantitation of catalpol and harpagide in rat plasma: application to a comparative pharmacokinetic study in normal and diabetic rats after oral administration of Zeng-Ye-Decoction. Biomed Chromatogr.
19. Pungitore CR, Leon LG, Garcia C, Martin VS, Tonn CE, et al. (2007) Novel antiproliferative analogs of the Taq DNA polymerase inhibitor catalpol. Bioorg Med Chem Lett 17: 1332-1335.
20. Calero CI, Beltran Gonzalez AN, Gasulla J, Alvarez S, Evelson P, et al. (2013) Quercetin antagonism of GAB receptors is prevented by ascorbic acid through a redox-independent mechanism. Eur J Pharmacol.
21. Hu Y, Wang S, Wu X, Zhang J, Chen R, et al. (2013) Chinese herbal medicine-derived compounds for cancer therapy: A focus on hepatocellular carcinoma. J Ethnopharmacol.
22. Lee DE, Chung MY, Lim TG, Huh WB, Lee HJ, et al. (2013) Quercetin Suppresses Intracellular ROS Formation, MMP Activation, and Cell Motility in Human Fibrosarcoma Cells. J Food Sci.
23. Wang G, Wang JJ, Chen XL, Du SM, Li DS, et al. (2013) The JAK2/STAT3 and mitochondrial pathways are essential for quercetin nanoliposome-induced C6 glioma cell death. Cell Death Dis 4: e746.
24. Ali Z, Smillie TJ, Khan IA (2013) Two spirostan steroid glycoside fatty esters from Dioscorea cayenensis. Nat Prod Commun 8: 323-326.
25. Cao X, Yao Z, Shao M, Chen H, Ye W, et al. (2010) Pharmacokinetics of methyl protodioscin in rats. Pharmazie 65: 359-362.
26. Hu K, Dong A, Yao X, Kobayashi H, Iwasaki S (1997) Antineoplastic agents. II. Four furostanol glycosides from rhizomes of Dioscorea collettii var. hypoglauca. Planta Med 63: 161-165.
27. Hu K, Yao X (2003) The cytotoxicity of methyl protodioscin against human cancer cell lines in vitro. Cancer Invest 21: 389-393.
28. Wang G, Chen H, Huang M, Wang N, Zhang J, et al. (2006) Methyl protodioscin induces G2/M cell cycle arrest and apoptosis in HepG2 liver cancer cells. Cancer Lett 241: 102-109.
29. Wang Z, Zhou J, Ju Y, Zhang H, Liu M, et al. (2001) Effects of two saponins extracted from the polygonatum Zanlanscianense pamp on the human leukemia (HL-60) cells. Biol Pharm Bull 24: 159-162.
30. Liu H, Zhang X, Du Y, Ji H, Li S, et al. (2012) Leonurine protects brain injury by increased activities of UCP4, SOD, CAT and Bcl-2, decreased levels of MDA and Bax, and ameliorated ultrastructure of mitochondria in experimental stroke. Brain Res 1474: 73-81.
31. Liu X, Pan L, Wang X, Gong Q, Zhu YZ (2012) Leonurine protects against tumor necrosis factor-alpha-mediated inflammation in human umbilical vein endothelial cells. Atherosclerosis 222: 34-42.
32. Liu XH, Pan LL, Deng HY, Xiong QH, Wu D, et al. (2013) Leonurine (SCM-198) attenuates myocardial fibrotic response via inhibition of NADPH oxidase 4. Free Radic Biol Med 54: 93-104.
33. Norata GD, Catapano AL (2012) Leonurine: a new comer in the natural compounds affecting atherosclerosis. Atherosclerosis 224: 37-38.
34. Kapoor S (2013) Digoxin and its Antineoplastic Properties: An Evolving Role in Oncology. J Pediatr Hematol Oncol.
35. Kubesova HM, Weber P, Meluzinova H, Bielakova K, Matejovsky J (2013) Benefits and pitfalls of cardiovascular medication in seniors. Wien Klin Wochenschr.
36. Sand CR, Leiria TL, Kalil RA (2013) Assessment of the adherence of cardiologists to guidelines for the treatment of atrial fibrillation. Arq Bras Cardiol.
37. Moffett BS, Valdes SO, Kim JJ (2013) Possible digoxin toxicity associated with concomitant ciprofloxacin therapy. Int J Clin Pharm.
38. Holliday DL, Speirs V (2011) Choosing the right cell line for breast cancer research. Breast Cancer Res 13: 215.